Introduction
Coronary Artery Bypass Grafting (CABG) remains a cornerstone treatment for advanced heart disease. However, postoperative complications can significantly impact recovery, with Acute Kidney Injury (AKI) being one of the most prevalent and serious. AKI occurs in up to 30% of cardiac surgery patients and is a primary driver of long-term morbidity and mortality.
While Diabetes Mellitus (DM) is a recognized risk factor for renal complications, the specific influence of different DM management strategies—specifically oral medications versus insulin—on the severity and incidence of post-CABG AKI has remained unclear. This multi-centre study investigates whether the type of DM treatment serves as a critical predictor for renal outcomes following surgery.
Methods
Researchers conducted an observational cohort study using data from the Jiangsu Province CABG Registry in China, encompassing 13 cardiac centers. The study analyzed 4,325 patients undergoing primary isolated CABG between September 2017 and August 2019.
Patients were stratified into three distinct cohorts based on their DM status and treatment regimen:
- No-DM Group: Non-diabetic patients (n=3,067).
- DM-oral Group: Patients managed with oral hypoglycemic agents (n=706).
- DM-insulin Group: Patients requiring insulin treatment (n=552).
AKI was defined and staged according to the Acute Kidney Injury Network (AKIN) criteria, which monitors serum creatinine levels and urine output. To ensure DM was the independent variable under test, the team employed multivariable analysis to adjust for 21 perioperative variables, including age, BMI, baseline renal function (eGFR), and heart function (LVEF).
Key Results
The overall incidence of AKI across the entire cohort was 13.7%. However, the risk was not distributed evenly among the groups:
- Incidence Rates: The AKI rate was 11.0% in the No-DM group, rising to 15.3% in the DM-oral group, and peaking at 26.3% in the DM-insulin group.
- Adjusted Risk: After adjusting for baseline factors, patients on oral medications faced a 26% increased risk (OR 1.26). Strikingly, patients on insulin treatment faced nearly a four-fold increase in risk (OR 3.92) compared to non-diabetic patients.
- Injury Severity: The insulin group also experienced more severe injury. In this cohort, 8.3% of AKI cases reached Stage 3 (the most severe), compared to only 3.5% in the non-diabetic group.
- Consistency: These trends remained consistent regardless of the patient's preoperative renal or cardiac function. Even patients with normal baseline eGFR (>60) or strong heart function (LVEF >0.50) showed significantly higher AKI rates if they had insulin-treated DM.
Discussion
The findings suggest that insulin-treated DM is a potent independent predictor of both the occurrence and severity of AKI after CABG. The authors hypothesize that chronic hyperglycemia in these patients induces a state of oxidative stress, systemic inflammation, and endothelial dysfunction. This environment may leave the kidneys "primed" for injury during the significant hemodynamic shifts and inflammatory responses triggered by heart surgery.
While the study provides robust real-world data, it is limited by its retrospective design and the lack of granular data regarding perioperative glucose control or the use of specific medications like ACE inhibitors during the hospital stay.
Conclusion
Diabetes mellitus, particularly when requiring insulin treatment, significantly increases the risk and severity of Acute Kidney Injury following CABG. This risk persists regardless of a patient's baseline heart or kidney health. These findings highlight the need for specialized perioperative management and potentially more aggressive glucose control strategies for insulin-dependent patients undergoing cardiac surgery.
Summary updated